Product Information
MIGRAINE 250-250-65 MG GELTAB is a generic product labeled by Cardinal Health, priced at $0.0663 per EA under NDC 70000061101. Its NADAC has been published 178 times since Feb 1, 2023.
Strength
250; 250; 65 mg/1; mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000061101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; ASPIRIN; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA075794On Market Since
8/8/2022
Pharmacological Classes
Price Statistics
The NADAC for MIGRAINE 250-250-65 MG GELTAB has been published 178 times since Feb 1, 2023, and over the history we have for it it has risen 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0663 per EA |
|---|---|
| All-time high | $0.0698 (Sep 11, 2024) |
| All-time low | $0.0584 (Apr 17, 2024) |
| 52-week high | $0.0691 |
| 52-week low | $0.0635 |
| Median price | $0.0641 |
| Average price | $0.0641 |
| Largest weekly change | +11.2% (Oct 18, 2023) |
| Weeks tracked | 178 |
| Tracking since | Feb 1, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the acetaminophen, aspirin, caffeine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MIGRAINE 250-250-65 MG GELTAB?
The current National Average Drug Acquisition Cost (NADAC) for MIGRAINE 250-250-65 MG GELTAB, manufactured by Cardinal Health, is $0.0663 per EA (NDC 70000061101), effective Jun 24, 2026.
How has the price of MIGRAINE 250-250-65 MG GELTAB changed over time?
Over the history we have for it, the NADAC for MIGRAINE 250-250-65 MG GELTAB has risen 4.1%. It has been tracked across 178 weekly CMS publications since Feb 1, 2023.
What are the highest and lowest recorded NADAC prices for MIGRAINE 250-250-65 MG GELTAB?
Since Feb 1, 2023, the NADAC for MIGRAINE 250-250-65 MG GELTAB has ranged from a low of $0.0584 (Apr 17, 2024) to a high of $0.0698 (Sep 11, 2024), with a median of $0.0641 per EA.
Are there cheaper alternatives to MIGRAINE 250-250-65 MG GELTAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MIGRAINE 250-250-65 MG GELTAB, so no direct lower-cost alternative is listed.
Who manufactures MIGRAINE 250-250-65 MG GELTAB?
MIGRAINE 250-250-65 MG GELTAB (NDC 70000061101) is labeled by Cardinal Health, and CMS classifies it as a generic product.
Related Drugs
Same classification